Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 584 of 1,261

  1. US 9884070

    Selective high-affinity polydentate ligands and methods of making such

    The Regents of the University of California · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

  2. US 9879260

    Micro-RNA regulation of bone loss

    The Board of Regents of the University of Texas System · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  3. US 9879032

    Pyridine compounds

    Sandford Burnham Prebys Medical Discovery Institute · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  4. US 9878996

    2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric oxide synthase

    Northwestern University · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  5. US 9879007

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  6. US 9878992

    GDF-8 inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  7. US 9878984

    Anti-cancer compounds

    Northwestern University · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  8. US 9878989

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  9. US 9879065

    T cell receptors recognizing MHC class II-restricted MAGE-A3

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  10. US 9878137

    Bioactive agent delivery devices and methods of making and using the same

    The Regents of the University of California · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  11. US 9878045

    Triorthogonal reagents for dual protein conjugation

    Regents of the University of Minnesota · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  12. US 9878026

    Infectious plasmodium sporozoites grown in vitro

    Sanaria Inc. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  13. US 9878033

    Immunogenic peptides for treatment of herpes simplex virus infection and conditions

    The Regents of the University of California · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  14. US 9878010

    Methods of treating metabolic disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  15. US 9878006

    Treatment of obesity and obesity related disorders by pharmalogical targeting of Kv1.3 potassium channels

    The Regents of the University of California · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  16. US 9877956

    Antiviral compounds and methods of use thereof

    TRANA DISCOVERY, INC. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  17. US 9878002

    Compositions and methods involving endogenous retrovirus proteins

    Regents of the University of Minnesota · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  18. US 9877988

    Method of treating lysosomal storage diseases using nucleases and a transgene

    Sangamo Therapeutics, Inc. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  19. US 9877937

    Compounds and methods for treating aberrant adrenocortical cell disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  20. US 9877990

    Compositions and methods for the treatment of wounds, disorders, and diseases of the skin

    Krystal Biotech, Inc. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  21. US 9878043

    Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  22. US 9878046

    Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects

    HALOZYME, INC. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  23. US 9879231

    Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  24. US 9878993

    DNA-PK inhibitors for treatment of cancer

    Vertex Pharmaceuticals Incorporated · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.